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Abstract
Ataxia-telangiectasia (A-T) is a complex multisystem disorder characterized by progressive neurological impairment,
variable immunodeficiency and oculo-cutaneous telangiectasia. A-T is a member of chromosomal breakage syn-
dromes and it is caused by a mutation in the ataxia-telangiectasia mutated (ATM) gene. Because of a wide clinical
heterogeneity, A-T is often difficult to diagnose in children.
We report an unusual case of a 3-year-old boy affected by A-T who presented exclusively with extensive cutaneous
granulomatosis and severe combined immunodeficiency, without neurological abnormalities, at the time of diag-
nosis. This case clearly emphasizes the variable presentation of A-T syndrome and highlights the difficulties in the
early diagnosis of A-T.
A-T should be considered in children with evidence of combined humoral and cellular immunodeficiency asso-
ciated with unexplained skin granulomatous lesions, even in the absence of the classic features of this syndrome.
Introduction
Ataxia-telangiectasia (A-T) is an autosomal recessive
genomic instability syndrome characterized by progressive
cerebellar ataxia, oculo-cutaneous telangiectasia, increased
radiosensibility, predisposition to lymphoid malignancies
and a variable degree of immunodeficiency. The preva-
lence is estimated to be between 1:100.000 [1] and
1:40.000 [2]. Both males and females are equally affected.
A-T results from mutations of a single gene, ATM
(ataxia-telangiectasia mutated), located on chromosome
11q22-23 [3,4], encoding a large basic protein involved
in cell cycle control and DNA damaging repair.
The diagnosis of A-T is based primarily on clinical find-
ings. Determination of serum alpha-fetoprotein (aFP) is an
important diagnostic marker as raised aFP level is found in
more than 90% of A-T patients. Confirmatory tests for A-T
include colony radiosensitivity assay and identification of
the ATM protein by immunoblotting [2,5,6].
We report the case of a 3-year-old boy affected by A-
T who presented exclusively with extensive cutaneous
granulomatousis and severe combined immunodefi-
ciency, without neurological abnormalities.
Case Report
A 3-year-old boy was referred to our Department of
Pediatrics with a history of cutaneous lesions, recurrent
otitis, repeated episodes of fever of unknown origin and
suspected immunodeficiency. He was born full term as
the second child of healthy non consanguineous parents.
At the age of 2, the child had chickenpox without
complications except for a residual erythematous, scaly
dermatitis characterized by small, red and indured
lesions on face, arms and legs [Fig. 1]. In the suspect of
hypersensitivity to insect bites, he was treated with topi-
cal treatment (steroids and tacrolimus) and oral antihis-
tamines without improvements.
Our first clinical examination revealed a failure to
thrive below the third percentile for height and below
the tenth for weight. Chest x-ray showed a lobar pneu-
monia. Neurological development was normal. Complete
blood count (CBC) revealed lymphopenia (range 840-
920/ml). Quantitative Polymerase Chain Reaction (PCR)
for EBV showed a massive proliferation (1.600.000
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copies/ml on blood; 1.000.000 copies/ml on serum) and
serological evaluation showed the absence of anti-EBNA
IgG. Immunological work-up revealed a combined
immunodeficiency [Tab. 1, 2]. Serum IgG and IgA levels
were low for the age, as well as IgG2 and IgG4. Specific
antibodies response against tetanus toxoid and HiB was
low, whereas titer versus Pneumococcal antigens was
undetectable despite of three vaccine doses performed.
Peripheral blood lymphocyte subsets repeatedly showed
a markedly reduced levels of both T and B cells; distri-
bution of naïve and memory T cells showed a marked
predominance of T cells with a memory phenotype
(CD4+CD45+RO+; CD8+CD45+RO+) and a corre-
sponding reduction of naïve T cells; HLA class I and II
expression on lymphocytes was normal. NK cells were
very increased (48%) with normal NK activity. Lympho-
cyte proliferative response to antigens and mitogens was
normal, except for a diminished response to PMA
+IONO. Thymic output, evaluated by measuring T-cell
receptor (TCR) rearrangement excision circles was extre-
mely low in both CD4+ and CD8+ T cells. Analysis of
TCR by CDR3 spectratyping revealed oligoclonal expan-
sion in the most of peripheral CD8+ and CD4+ T cells.
Skin biopsy showed granulomatous inflammation with an
infiltrate characterized by polymorphic lymphocyte and
Figure 1 Cutaneous granulomatous lesions. Erythematous, scaly
dermatitis characterized by small, red and indured lesions on face,
arms and legs.
Table 1 Immunological data
Parameter Results Age matched
controls
WBC/ml 5.700 5-16 × 10 3
Hb gr/dl 12 11.5-13
Plts/ml 370.000 250-550 × 10 3
Serum immunoglobulin mg/dl
IgA 10 27-173
IgM 61 62-257
IgG 293 462-1710
IgG1 287 280-830
IgG2 9 40-240
IgG3 2.4 6-130
IgG4 0.3 3-120
Lymphocyte phenotype
Absolute count/ml 840 1.7-6.9 × 10 3
CD3 304 (36.3%) 0.9-4.5 × 10 3
CD4 121 (14%) 0.5-2.4 × 10 3
CD4RA 22%
CD4RO 78%
CD8 153 (18.3%) 0.3-1.6 × 10 3
CD8RA 29%
CD8RO 71%
CD19 42 (4.9%) 0.2-2.1 × 10 3
CD16-56 467 (55.7%) 0.1-1 × 10 3
TRECs
CD4 absent 1.106 - 15.787
CD8 absent 1.106 - 15.787
Response to mitogens and
antigens (counts per minute)
none 439 > 430
PHA 33775 > 35000
OKT3 34410 >25000
PMA+IONO 4772 >25000
none 3069 >1250
Candida 9711 >5000
Tetanus toxoid 3231 > 5000
Table 2 Serological data after 3 vaccine doses
Parameter Results Reading
Tetanus toxoid IU/ml 0.1 >0.1 IU/ml
Haemophilus influenzae B mg/l 0.1 >1 μg/ml
S. Pneumoniae mg/l 3 >20 mg/l
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epithelioid cells; Periodic acid-Schiff (PAS), Giemsa, and
Ziehl-Neelsen staining of skin-biopsy specimens showed
no evidence of fungi or mycobacteria and PCR assays for
mycobacterium tuberculosis were negative. In situ analy-
sis of TCR repertoire of CD3 lymphocyte resulted com-
pletely skewed.
Intravenous immunoglobulin infusion at the dosage of
400 mg/Kg monthly and prophylactic treatment with tri-
methoprim-sulfamethoxazole was started; during this per-
iod a marked reduction of EBV viral load was observed.
Six months later the child experienced a bilateral acute
otitis that required a long and multiple antibiotic therapy.
Based on the male-gender, hypogammaglobulinemia
and high EBV replication rate, we firstly ruled out Lym-
phoproliferative X-linked Syndrome (XLP) and XIAP
deficiency by molecular analysis [7]. Schuetz et al.
reported a hypomorphic heterozygous RAG mutation
with skin granulomatous lesions associated with second-
ary complications of EBV infection and severe immuno-
logical abnormalities [8]; molecular analysis for RAG1/2
resulted negative. Even in the absence of a severe clini-
cal picture, immunological B and T cells alterations led
us to consider a leaky SCID. Sequencing of common g-
chain and IL7-R genes and dosage of ADA enzyme in
white blood cells and plasma resulted normal. There
was no evidence of maternal engraftment in the patient’s
peripheral blood by chimerism analysis.
In the suspect of a double strands break repair defect,
radiosensitivity test was performed, showing an
increased number of chromosomal aberrations. Alpha-
fetoprotein (aFP) serum value repeatedly resulted
increased (135 ng/ml, n.v. <10 ng/ml) and Western Blot-
ting showed the absence of ATM protein.
Characterization of the ATM gene mutations are in
progress.
Phenotypic heterogeneity has long been identified in
both laboratory and clinical features of A-T, ranging from
the classic form with typical symptoms to unusual disease
presentation. Neurological involvement (i.e. cerebellar
ataxia and dysarthria) and ocular telangectasia are the hall-
marks of A-T. Nevertheless, milder forms of A-T, which
are characterized by late onset or slow progression of neu-
romotor dysfunction, have been described and diagnosed
even among adults during evaluation on unknown ataxia.
The typical cutaneous manifestation of the disease is ocu-
lar telangectasia although some patients have no telangec-
tasia, even in adulthood; cutaneous granulomatosis with
no identifiable infectious origin occurs rarely in children
with primary immunodeficiency [8-10]. These cutaneous
granulomas have been previously described in common
variable immunodeficiency [9,11-13], chronic granuloma-
tous disease, X-linked hypogammaglobulinemia [14,15]
but rarely in A-T [16-19]. Furthermore, we did not see
resolution of granulomas after neither the local
immunosuppressive therapy, nor the treatment with intra-
venous immunoglobulin, as it has been reported in some
patients with common variable immunodeficiency
[9,20,21].
Similarly to the phenotypic features, a wide variability
of immunological defects exists in patients with A-T
syndrome, ranging from the absence of immune defects
to severe immunodeficiency with recurrent infections
[22,23]. Low levels of IgG, IgA and IgE are observed in
more than 80% of the patients, whereas severe com-
bined immunodeficiency with recurrent infections occur
rarely. In our patient, immunological abnormalities were
so severe that led us to suspect a combined immunode-
ficiency. Diagnosis led us to reveal A-T even in child’s
elder sister (8-years-old) for whom a wrong spastic par-
esis diagnosis was previously made elsewhere. She con-
versely presented a common clinical phenotype of A-T,
showing progressive neurological degeneration with
ataxia, dysarthria, dyskinesia, dystonia and oculo-cuta-
neous telangiectasia. Her immunological work-up only
revealed a mild lymphopenia with an IgA defect. The
different clinical picture seen in patients with defects of
that same gene can be caused by specific mutations,
other genetic factors or epigenetic mechanism. Previous
studies have failed to indicate a specific correlation
between the amount of ATM protein and radiosensitiv-
ity. However, the results of various studies suggest a clear
correlation between preservation of neurological function,
decreased radiosensitivity and level of normal ATM pro-
tein kinase activity. Interestingly, there are siblings, as our
patients, who reported absent ATM protein but clinically
and laboratory distinct phenotypes [23,24]. Thus, our
case supports the lack of a strict genotype-phenotype cor-
relation[2,22-26] suggesting that the heterogeneity of A-T
is much broader than initially recognized and that A-T
represents a complex spectrum of the disease shaped by
the genetic mutations, host characteristics, pathogens
(EBV) and environmental factors.
The prevalence of the disease reported in the literature
is very variable and estimated to be 1:40,000-100,000
births [1,2]; this is probably due to the wide clinical het-
erogeneity that often leads physicians to an incorrect or
missed diagnosis. Atypical presentation of our patient
caused a delay of diagnosis; there should be a high index
of suspect for A-T among children with recurrent infec-
tions and immunodeficiency, even in the absence of neu-
rological abnormalities. Accordingly, screening with serum
alpha-fetoprotein, a simple, rapid and reliable test for A-T,
should be part of the evaluation of children with any con-
genital immunodeficiency. A delayed diagnosis can often
affect the clinical evolution and influence the management
of A-T patients and their relatives [1,27]. Early diagnosis
alerts the physicians to limit ionizing radiations exposure,
including the diagnostic methods. Also, early diagnosis
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allows genetic counseling as well as the identification of
the carrier parents who may have an increased cancer risk,
particularly breast cancer in women [1,28].
Conclusion
In conclusion, A-T syndrome should be considered in
children with an evidence of combined humoral and cel-
lular immunodeficiency and otherwise unexplained
granulomatous skin lesions.
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